Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04965753
Title FHD-609 in Subjects With Advanced Synovial Sarcoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Foghorn Therapeutics Inc.
Indications

synovial sarcoma

Therapies

FHD-609

Age Groups: senior | child | adult
Covered Countries USA | FRA | ESP


No variant requirements are available.